327 related articles for article (PubMed ID: 9508178)
1. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.
Ladenstein R; Philip T; Lasset C; Hartmann O; Garaventa A; Pinkerton R; Michon J; Pritchard J; Klingebiel T; Kremens B; Pearson A; Coze C; Paolucci P; Frappaz D; Gadner H; Chauvin F
J Clin Oncol; 1998 Mar; 16(3):953-65. PubMed ID: 9508178
[TBL] [Abstract][Full Text] [Related]
2. Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation.
Ladenstein R; Lasset C; Hartmann O; Frappaz D; Garaventa A; Klingebiel T; Zucker JM; Coze C; Burdach S; Gadner H
J Clin Oncol; 1993 Dec; 11(12):2330-41. PubMed ID: 8246022
[TBL] [Abstract][Full Text] [Related]
3. 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party.
Philip T; Ladenstein R; Lasset C; Hartmann O; Zucker JM; Pinkerton R; Pearson AD; Klingebiel T; Garaventa A; Kremens B; Bernard JL; Rosti G; Chauvin F
Eur J Cancer; 1997 Oct; 33(12):2130-5. PubMed ID: 9516868
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of risk factors for patients with stage 4 neuroblastoma who were older than 18 months at diagnosis: a report from a single institute in Shanghai, China.
Cai J; Pan C; Tang Y; Chen J; Zhou M; Li B; Xue H; Shen S; Gao Y; Zhang A; Tang J
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1327-1335. PubMed ID: 28283783
[TBL] [Abstract][Full Text] [Related]
5. Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry.
Ladenstein R; Lasset C; Pinkerton R; Zucker JM; Peters C; Burdach S; Pardo N; Dallorso S; Coze C
Bone Marrow Transplant; 1995 May; 15(5):697-705. PubMed ID: 7670398
[TBL] [Abstract][Full Text] [Related]
6. [The European experience with megadose therapy and autologous bone marrow transplantation in solid tumors with poor prognosis Ewing sarcoma, germ cell tumors and brain tumors)].
Ladenstein R; Gadner H; Hartmann O; Pico J; Biron P; Thierry P
Wien Med Wochenschr; 1995; 145(2-3):55-7. PubMed ID: 7762255
[TBL] [Abstract][Full Text] [Related]
7. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
Stram DO; Matthay KK; O'Leary M; Reynolds CP; Haase GM; Atkinson JB; Brodeur GM; Seeger RC
J Clin Oncol; 1996 Sep; 14(9):2417-26. PubMed ID: 8823319
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution.
Hartmann O; Valteau-Couanet D; Vassal G; Lapierre V; Brugières L; Delgado R; Couanet D; Lumbroso J; Benhamou E
Bone Marrow Transplant; 1999 Apr; 23(8):789-95. PubMed ID: 10231141
[TBL] [Abstract][Full Text] [Related]
9. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
[TBL] [Abstract][Full Text] [Related]
10. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
[TBL] [Abstract][Full Text] [Related]
11. Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT Group.
Garaventa A; Rondelli R; Lanino E; Dallorso S; Dini G; Bonetti F; Arrighini A; Santoro N; Rossetti F; Miniero R; Andolina M; Amici A; Indolfi P; Lo Curto M; Favre C; Paolucci P; Pession A; De Bernardi B
Bone Marrow Transplant; 1996 Jul; 18(1):125-30. PubMed ID: 8832005
[TBL] [Abstract][Full Text] [Related]
12. [High-dose therapy followed by auto HSCT in children--with advanced neuroblastoma in four transplant centres in Poland].
Zaucha-Prazmo A; Drabko K; Wójcik B; Choma M; Kałwak K; Gorczyńska E; Turkiewicz D; Słociak M; Ussowicz M; Dyla A; Chybicka A; Goździk J; Ratajczak M; Styczyński J; Debski R; Wysocki M; Kowalczyk J
Med Wieku Rozwoj; 2006; 10(3 Pt 1):775-84. PubMed ID: 17317908
[TBL] [Abstract][Full Text] [Related]
13. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.
Berthold F; Boos J; Burdach S; Erttmann R; Henze G; Hermann J; Klingebiel T; Kremens B; Schilling FH; Schrappe M; Simon T; Hero B
Lancet Oncol; 2005 Sep; 6(9):649-58. PubMed ID: 16129365
[TBL] [Abstract][Full Text] [Related]
14. Indication and limits of megatherapy and bone marrow transplantation in high-risk neuroblastoma: a single centre analysis of prognostic factors.
Ladenstein R; Favrot M; Lasset C; Bouffet E; Philip I; Combaret V; Chauvin F; Brunat-Mentigny M; Biron P; Philip T
Eur J Cancer; 1993; 29A(7):947-56. PubMed ID: 8499148
[TBL] [Abstract][Full Text] [Related]
15. Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: a pilot study.
Fukuda M; Miyajima Y; Miyashita Y; Horibe K
J Pediatr Hematol Oncol; 2001 Jan; 23(1):10-3. PubMed ID: 11196262
[TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97.
Schmidt M; Simon T; Hero B; Schicha H; Berthold F
Eur J Cancer; 2008 Jul; 44(11):1552-8. PubMed ID: 18424129
[TBL] [Abstract][Full Text] [Related]
17. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
18. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?
Philip T; Zucker JM; Bernard JL; Lutz P; Bordigoni P; Plouvier E; Robert A; Roché H; Souillet G; Bouffet E
J Clin Oncol; 1991 Jun; 9(6):1037-44. PubMed ID: 2033417
[TBL] [Abstract][Full Text] [Related]
19. Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases.
Dini G; Lanino E; Garaventa A; Rogers D; Dallorso S; Viscoli C; Castagnola E; Manno G; Brisigotti M; Rosanda C
J Clin Oncol; 1991 Jun; 9(6):962-9. PubMed ID: 2033431
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria.
Burdach S; van Kaick B; Laws HJ; Ahrens S; Haase R; Körholz D; Pape H; Dunst J; Kahn T; Willers R; Engel B; Dirksen U; Kramm C; Nürnberger W; Heyll A; Ladenstein R; Gadner H; Jürgens H; Go el U
Ann Oncol; 2000 Nov; 11(11):1451-62. PubMed ID: 11142486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
